GORT

Reviews

The Myc Oncogene Is A Global Regulator Of The Immune Response

Di: Everly

Europe PMC is an archive of life sciences journal literature.

(4) The classic oncogene MYC induces immune escape by inhibiting innate immunity, and when the WNT/β-catenin pathway and the downstream molecule MYC are inhibited, especially MYC,

Genes | Free Full-Text | MYC—Master Regulator of the Cancer Epigenome ...

MYC: Master Regulator of Cell Death and Tumor Progression

The immune checkpoint regulators are key components of the immune response that can be regulated by oncogenic pathways , as has been seen particularly in MYC-driven tumors and

MYC oncogene is a transcription factor with a wide array of functions affecting cellular activities such as cell cycle, apoptosis, DNA damage response, and hematopoiesis.

  • The effects of MYC on tumor immunity and immunotherapyThe effects of MYC on tumor immunity and immunotherapy
  • MYC: Master Regulator of Cell Death and Tumor Progression
  • MYC: Master Regulator of Immune Privilege.

In the past few years, studies have demonstrated that MYC signalling can enable tumour cells to dysregulate their microenvironment and evade the host immune response.

MYC in Immunity . Immune response is an evolutionarily conserved process that protects multicellular organism from pathogens. The immune system is comprised of a variety of cells

the immune response and contribute to tumorigenesis. Oncogenes Regulate the Immune Response Many studies report that oncogenes regulate components of the immune response,

Oncogenes such as MYC may drive tumor growth not only through their intrinsic influence on cellular proliferation but also through their regulation of immune checkpoints that

Proto-oncogene and Oncogene Mediated Regulation of Immune Privilege We suggest a model where in normal physiological situations requiring rapid proliferative expansion, such as during

MYC, Metabolism, and Cancer

regulator of the adaptive immune response (24, 25) (fig. S1A). These and similar molecules are often overexpressed on human tumors (22, 25). Therapeutic suppression of PD-L1 and other

First, is MYC a general regulator of the immune response? This remains to be shown because a multitude of immune checkpoints, chemokines, and host immune effector mechanisms are

Oncogenes such as MYC may drive tumor growth not only through their intrinsic influence on cellular proliferation but also through their regulation of immune checkpoints that enables

Expression of many oncogenes or loss of tumor suppressors induces the expression of immune checkpoints that regulate the immune response, such as PD-L1. We discuss here how

In the past few years, studies have demonstrated that MYC signalling can enable tumour cells to dysregulate their microenvironment and evade the host immune response. Herein, we discuss

Expression of many oncogenes or loss of tumor suppressors induces the expression of immune checkpoints that regulate the immune response, such as PD-L1. We discuss here how

Cancer comprises a heterogeneous disease, characterized by diverse features such as constitutive expression of oncogenes and/or downregulation of tumo

c-Myc is a member of the superfamily of basic helix-loop-helix leucine zipper (bHLHLZ) DNA binding proteins. It is a global transcriptional regulator with the ability to

Role of c-Myc in lung cancer: Progress, challenges, and prospects

The oncogene MYC is dysregulated in a host of human cancers, and as an important point of convergence in multitudinous oncogenic signaling pathways, it plays a crucial role in tumor

Background: MYC oncogene is deregulated in 70% of all human cancers and is associated with multiple oncogenic functions including immunosuppression in the tumor microenvironment. The

The oncogene MYC is dysregulated in a host of human cancers, and as an important point of convergence in multitudinous oncogenic signaling pathways, it plays a

Gouw and Margulis et al. present comprehensive evidence that the oncogene MYC collaborates with the transcription factor SREBP1 in controlling lipogenesis to promote

In the past few years, studies have demonstrated that MYC signalling can enable tumour cells to dysregulate their microenvironment and evade the host immune response. Herein, we discuss

A big step for MYC-targeted therapies: Trends in Cancer

Here, we propose that MYC regulates these programs in a manner that is coordinated with a global influence on the host immune response. MYC had been presumed to contribute to

Summary. The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its precise oncogenic role enigmatically elusive. The evidence to date suggests that MYC triggers

The MYC oncogene (also known as c- MYC) is part of a superfamily of genes with products that are among the most commonly activated in human cancers 1 –4. MYC is a

Here we propose that MYC regulates these programs in a manner that is coordinated with a global influence on the host immune response. MYC had been presumed to contribute to tumorigenesis

Here, we propose that MYC regulates these programs in a manner that is coordinated with a global influence on the host immune response. MYC had been presumed to contribute to tumorigenesis through tumor cell–intrinsic

The MYC proto-oncogene encodes a master transcriptional regulator that is frequently dysregulated in human cancer. Decades of efforts have failed to identify a MYC

Here, we propose that MYC regulates these programs in a manner that is coordinated with a global influence on the host immune response. MYC had been presumed to

Here, we propose that MYC regulates these programs in a manner that is coordinated with a global influence on the host immune response. MYC had been presumed to

MYC gene has become one of the most investigated oncogenes for regulating programmed cell death and tumor growth. MYC is a transcription factor that regulates the